跳至主要内容
临床试验/DRKS00030018
DRKS00030018已完成4 期

Management of split-thickness skin graft donor site: An open, prospective, randomized, controlled clinical trial for comparison of three different dressing materials.

QRSKIN GmbH0 个研究点目标入组 69 人开始时间: 2022年8月15日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
69

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 100 Years(—)
性别
All

入选标准

  • patients scheduled for elective skin grafting were eligible for inclusion in the study

排除标准

  • age under 18 years, pregnancy / lactation, local infection at planned split-thickness skin grafting donor site, hypersensitivity to dressing components, malignant or autoimmune disease, vasculitis, connective tissue diseases, immune system disorders, chemo-, radio- and immunosuppressive therapy within 30 days prior to study enrolment, systemic corticosteroids (intake > 10mg/day), drug abuse, excessive alcohol consumption, recent participation in other clinical trials within 4 weeks before study enrolment.

研究者

发起方
QRSKIN GmbH

相似试验